Cargando…

Advanced statistical methods and designs for clinical trials for COVID-19

Detalles Bibliográficos
Autores principales:	Shan, Guogen, Wang, Weizhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833547/ https://www.ncbi.nlm.nih.gov/pubmed/33408032 http://dx.doi.org/10.1016/j.ijantimicag.2020.106167

Ejemplares similares

Response to advances statistical methods and designs for clinical trials for COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Statistical advances in clinical trials and clinical research
por: Shan, Guogen, et al.
Publicado: (2018)

Novel Clinical Trial Design for the Study of the Effect of Prone Position on Clinical Outcomes of COVID-19 Patients
por: Yarahmadi, Sajad, et al.
Publicado: (2022)

Exact statistical inference for categorical data
por: Shan, Guogen
Publicado: (2016)

Unsubstantiated conclusions from improper statistical design and analysis of a randomized controlled trial
por: George, Brandon J, et al.
Publicado: (2016)

Minimax and admissible adaptive two-stage designs in phase II clinical trials
por: Shan, Guogen, et al.
Publicado: (2016)

Study design and statistics in the epidemiology of breast cancer
por: Maraqa, L, et al.
Publicado: (2006)

The Impact of COVID-19 on Dermatology Clinical Trials
por: Desai, Sheena, et al.
Publicado: (2021)

Inappropriate statistical method in a parallel-group randomized controlled trial results in unsubstantiated conclusions
por: Dimova, Rositsa B., et al.
Publicado: (2016)

Reply: Study design and statistics in epidemiology of breast cancer
por: Garcia-Closas, M, et al.
Publicado: (2006)

Modifications to Communities for Healthy Living trial design resulting from COVID-19
por: Davison, Kirsten K., et al.
Publicado: (2020)

Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients
por: Piconi, Stefania, et al.
Publicado: (2023)

Exclusion of Older Adults in COVID-19 Clinical Trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2020)

Use of sulforaphane in COVID-19: Clinical trials are needed
por: Kow, Chia Siang, et al.
Publicado: (2022)

Perceived discrimination and mental health among the Chinese diaspora during COVID-19
por: Chen, Youli, et al.
Publicado: (2021)

Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
por: Brito-Azevedo, Anderson
Publicado: (2020)

Recent pharmacological advances on genistein in clinical trials
por: Mathew, Shimy, et al.
Publicado: (2020)

Epigenetic clocks for gestational age: statistical and study design considerations
por: Simpkin, Andrew J., et al.
Publicado: (2017)

Using Advanced Statistical Models to Predict the Non-Communicable Diseases
por: MADADIZADEH, Farzan, et al.
Publicado: (2015)

Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials
por: Hsiehchen, David, et al.
Publicado: (2020)

Designing of clinical information update system for clinicians on Covid-19: A commentary
por: Ashrafi-Rzi, Hasan, et al.
Publicado: (2020)

The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19
por: Ashraf, Mohammad Ali, et al.
Publicado: (2020)

Bayesian Statistical Methods and Their Valuable Applications in the Pharmaceutical Sciences
por: MADADIZADEH, Farzan, et al.
Publicado: (2016)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Waste in COVID-19 clinical trials conducted in western Europe
por: Dal-Ré, Rafael, et al.
Publicado: (2020)

Statistical relationship networks in psychiatric research: The case of delirium in the context of COVID-19()
por: Ramos-Vera, Cristian
Publicado: (2021)

Clinical and radiological improvement of protracted COVID-19 and Good syndrome secondary to advanced thymoma
por: Cerezoli, M. Tenorio, et al.
Publicado: (2022)

Clinical challenges of managing advanced AIDS in the tropics: Histoplasmosis, COVID-19, and shigellosis coinfections
por: Ortiz-Martínez, Yeimer, et al.
Publicado: (2022)

Metformin in COVID-19: clinical trials are needed to prove its benefits
por: Kow, Chia Siang, et al.
Publicado: (2022)

Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic
por: Ahmed, Mohamed E., et al.
Publicado: (2021)

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
por: Trøseid, Marius, et al.
Publicado: (2022)

Plant polyphenols effect on gut microbiota: Recent advancements in clinical trials
por: Chelakkot, Ayshwarya Lakshmi, et al.
Publicado: (2021)

Letter of concern on evaluating the consistency between two clinical COVID-19 diagnostic methods
por: Li, Ming, et al.
Publicado: (2022)

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
por: Rimassa, Lorenza, et al.
Publicado: (2017)

Inappropriate data selection and statistical method lead to overestimated mortality for hospitalised HIV/AIDS patients
por: Wang, J.
Publicado: (2020)

The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide
por: Yang, Geliang, et al.
Publicado: (2021)

COVID 19 pandemic, status of clinical trials in Africa on May 2020: need to reinforce
por: Nkeck, Jan René, et al.
Publicado: (2020)

Proper Reporting of Statistical Parameters in Clinical Trials Published in Indian Medical Journals. Is Inclusion of Statistician Play any Significant Role?
por: Jaykaran,, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k39d12h57g3lcqtsu9b1kknc8j